RVX-208
CAS No. 1044870-39-4
RVX-208 ( RVX208; RVX 208; RVX-208; Apabetalone )
Catalog No. M10222 CAS No. 1044870-39-4
RVX-208 is a potent BET bromodomain inhibitor with IC50 of 0.510 μM for BD2 in a cell-free assay, about 170-fold selectivity over BD1. Phase 2.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 35 | In Stock |
|
25MG | 65 | In Stock |
|
50MG | 107 | In Stock |
|
100MG | 156 | In Stock |
|
500MG | 386 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRVX-208
-
NoteResearch use only, not for human use.
-
Brief DescriptionRVX-208 is a potent BET bromodomain inhibitor with IC50 of 0.510 μM for BD2 in a cell-free assay, about 170-fold selectivity over BD1. Phase 2.
-
DescriptionRVX-208 is a potent BET bromodomain inhibitor with IC50 of 0.510 μM for BD2 in a cell-free assay, about 170-fold selectivity over BD1. Phase 2.
-
SynonymsRVX208; RVX 208; RVX-208; Apabetalone
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorBD2
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number1044870-39-4
-
Formula Weight370.40
-
Molecular FormulaC20H22N2O5
-
Purity>98%(HPLC)
-
SolubilityDMSO: 74 mg/mL (199.78 mM)
-
SMILESO=C1NC(C2=CC(C)=C(OCCO)C(C)=C2)=NC3=C1C(OC)=CC(OC)=C3
-
Chemical Name2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Picaud S, et al. Proc Natl Acad Sci U S A. 2013, 110(49), 19754-19759.
molnova catalog
related products
-
SGC-SMARCA-BRDVIII
SGC-SMARCA-BRDVIII is a potent and selective inhibitor of SMARCA2, SMARCA4, PB1(2), PB1(3) and PB1(5) with Kds of 35 nM, 36 nM, 3.7 μM, 2.0 μM and 13 nM, respectively.
-
PFI-1
PFI-1 is a selective BET (bromodomain-containing protein) inhibitor for BRD4 with IC50 of 0.22 μM in a cell-free assay.
-
Menin-MLL inhibitor ...
Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6).